October 7, 2019 / 8:29 AM / 8 months ago

Accelmed seeks to raise $100 million for fourth health tech fund

JERUSALEM (Reuters) - Accelmed, a U.S.-Israel group of funds investing in medical device and digital health companies, said on Monday it was establishing a new fund with the aim of raising and managing $100 million.

The Accelmed Ventures II fund will invest in Israeli and global pre-revenue health tech startups. Vincent Tchenguiz, a British businessman born in Iran, has committed to invest $15 million in the fund.

This is the fourth fund established by the Accelmed group, which manages more than $300 million through Accelmed Ventures and private equity fund Accelmed Partners.

Accelmed Ventures I, which was established in 2011, has had a number of exits, including Eximo Medical, purchased by AngioDynamics Inc for $66 million. Portfolio company Endospan signed an option agreement to be acquired by CryoLife Inc for up to $450 million, pursuant to receiving approval by the U.S. Food and Drug Administration.

Reporting by Steven Scheer; Editing by Tova Cohen

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below